A Nomogram for Predicting Overall Survival in Primary Central Nervous System Lymphoma: A Retrospective Study

Yunan Ling,* Xiaqi Miao,* Xiang Zhou,* Jingjing Ma, Zhiguang Lin, Qing Li, Mengxue Zhang, Yan Ma, Bobin Chen Department of Hematology, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence...

Full description

Saved in:
Bibliographic Details
Main Authors: Ling Y, Miao X, Zhou X, Ma J, Lin Z, Li Q, Zhang M, Ma Y, Chen B
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Journal of Inflammation Research
Subjects:
Online Access:https://www.dovepress.com/a-nomogram-for-predicting-overall-survival-in-primary-central-nervous--peer-reviewed-fulltext-article-JIR
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823857950819614720
author Ling Y
Miao X
Zhou X
Ma J
Lin Z
Li Q
Zhang M
Ma Y
Chen B
author_facet Ling Y
Miao X
Zhou X
Ma J
Lin Z
Li Q
Zhang M
Ma Y
Chen B
author_sort Ling Y
collection DOAJ
description Yunan Ling,* Xiaqi Miao,* Xiang Zhou,* Jingjing Ma, Zhiguang Lin, Qing Li, Mengxue Zhang, Yan Ma, Bobin Chen Department of Hematology, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bobin Chen, Department of Hematology, Huashan Hospital, Fudan University, 12 Urumuqi Road (Middle), Shanghai, 200040, People’s Republic of China, Email bbchen@fudan.edu.cnPurpose: Current prognostic scoring systems for newly diagnosed primary central nervous system lymphoma (PCNSL), such as IELSG prognostic score and MSKCC prognostic score, are widely used but have limitations in clinical practice. This study aimed to develop a novel prognostic model based on real clinical data and compare it with existing systems.Patients and Methods: A total of 288 patients newly diagnosed with PCNSL were recruited. Patients were randomly allocated to the development and validation cohorts. The least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox regression analysis were used to identify the risk factors for overall survival (OS) and construct a nomogram. Additionally, Kaplan-Meier survival curves were plotted to show the stratification ability of the risk groups.Results: Eastern Cooperative Oncology Group performance status (ECOG-PS), albumin, and two inflammatory biomarkers D-Dimer, and neutrophil-to-lymphocyte ratio (NLR)—were independent predictors of inferior OS. The prognostic model demonstrated concordance Index (C-index) of 0.731 and 0.679 in the development and validation cohorts, respectively. In terms of the time dependent area under the curve (AUC) values for OS, the development cohort exhibited values of 0.765, 0.762, and 0.812 for 1-year, 3-year, and 5-year OS, respectively. The corresponding AUC values in the validation cohort were 0.711, 0.731, and 0.840, respectively. The calibration curves showed excellent concordance. The novel prognostic model also provided superior risk stratification for patients with PCNSL compared with existing scoring systems.Conclusion: This study presents a novel prognostic model for predicting the OS of patients with newly diagnosed PCNSL. The model accurately and effectively stratifies the prognosis of patients with PCNSL and offers valuable clinical guidance for decision making.Keywords: PCNSL, prognostic model, risk stratification, NLR, albumin, D-Dimer
format Article
id doaj-art-01de073b1ad3409187e23fdf40256421
institution Kabale University
issn 1178-7031
language English
publishDate 2025-02-01
publisher Dove Medical Press
record_format Article
series Journal of Inflammation Research
spelling doaj-art-01de073b1ad3409187e23fdf402564212025-02-11T17:30:56ZengDove Medical PressJournal of Inflammation Research1178-70312025-02-01Volume 1820912103100025A Nomogram for Predicting Overall Survival in Primary Central Nervous System Lymphoma: A Retrospective StudyLing YMiao XZhou XMa JLin ZLi QZhang MMa YChen BYunan Ling,* Xiaqi Miao,* Xiang Zhou,* Jingjing Ma, Zhiguang Lin, Qing Li, Mengxue Zhang, Yan Ma, Bobin Chen Department of Hematology, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bobin Chen, Department of Hematology, Huashan Hospital, Fudan University, 12 Urumuqi Road (Middle), Shanghai, 200040, People’s Republic of China, Email bbchen@fudan.edu.cnPurpose: Current prognostic scoring systems for newly diagnosed primary central nervous system lymphoma (PCNSL), such as IELSG prognostic score and MSKCC prognostic score, are widely used but have limitations in clinical practice. This study aimed to develop a novel prognostic model based on real clinical data and compare it with existing systems.Patients and Methods: A total of 288 patients newly diagnosed with PCNSL were recruited. Patients were randomly allocated to the development and validation cohorts. The least absolute shrinkage and selection operator (LASSO) regression and multivariate Cox regression analysis were used to identify the risk factors for overall survival (OS) and construct a nomogram. Additionally, Kaplan-Meier survival curves were plotted to show the stratification ability of the risk groups.Results: Eastern Cooperative Oncology Group performance status (ECOG-PS), albumin, and two inflammatory biomarkers D-Dimer, and neutrophil-to-lymphocyte ratio (NLR)—were independent predictors of inferior OS. The prognostic model demonstrated concordance Index (C-index) of 0.731 and 0.679 in the development and validation cohorts, respectively. In terms of the time dependent area under the curve (AUC) values for OS, the development cohort exhibited values of 0.765, 0.762, and 0.812 for 1-year, 3-year, and 5-year OS, respectively. The corresponding AUC values in the validation cohort were 0.711, 0.731, and 0.840, respectively. The calibration curves showed excellent concordance. The novel prognostic model also provided superior risk stratification for patients with PCNSL compared with existing scoring systems.Conclusion: This study presents a novel prognostic model for predicting the OS of patients with newly diagnosed PCNSL. The model accurately and effectively stratifies the prognosis of patients with PCNSL and offers valuable clinical guidance for decision making.Keywords: PCNSL, prognostic model, risk stratification, NLR, albumin, D-Dimerhttps://www.dovepress.com/a-nomogram-for-predicting-overall-survival-in-primary-central-nervous--peer-reviewed-fulltext-article-JIRpcnslprognostic modelrisk stratificationnlralbumind-dimer
spellingShingle Ling Y
Miao X
Zhou X
Ma J
Lin Z
Li Q
Zhang M
Ma Y
Chen B
A Nomogram for Predicting Overall Survival in Primary Central Nervous System Lymphoma: A Retrospective Study
Journal of Inflammation Research
pcnsl
prognostic model
risk stratification
nlr
albumin
d-dimer
title A Nomogram for Predicting Overall Survival in Primary Central Nervous System Lymphoma: A Retrospective Study
title_full A Nomogram for Predicting Overall Survival in Primary Central Nervous System Lymphoma: A Retrospective Study
title_fullStr A Nomogram for Predicting Overall Survival in Primary Central Nervous System Lymphoma: A Retrospective Study
title_full_unstemmed A Nomogram for Predicting Overall Survival in Primary Central Nervous System Lymphoma: A Retrospective Study
title_short A Nomogram for Predicting Overall Survival in Primary Central Nervous System Lymphoma: A Retrospective Study
title_sort nomogram for predicting overall survival in primary central nervous system lymphoma a retrospective study
topic pcnsl
prognostic model
risk stratification
nlr
albumin
d-dimer
url https://www.dovepress.com/a-nomogram-for-predicting-overall-survival-in-primary-central-nervous--peer-reviewed-fulltext-article-JIR
work_keys_str_mv AT lingy anomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT miaox anomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT zhoux anomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT maj anomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT linz anomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT liq anomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT zhangm anomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT may anomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT chenb anomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT lingy nomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT miaox nomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT zhoux nomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT maj nomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT linz nomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT liq nomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT zhangm nomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT may nomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy
AT chenb nomogramforpredictingoverallsurvivalinprimarycentralnervoussystemlymphomaaretrospectivestudy